Two possibilities how to increase the efficacy of antidotal treatment of nerve agent poisonings
Language English Country Netherlands Media print
Document type Journal Article, Research Support, Non-U.S. Gov't, Review
PubMed
22360668
DOI
10.2174/138955712798869011
PII: MRMC-12-1-24
Knihovny.cz E-resources
- MeSH
- Antidotes pharmacology therapeutic use MeSH
- Chemical Warfare Agents poisoning MeSH
- Cholinesterase Inhibitors poisoning MeSH
- Humans MeSH
- Oximes therapeutic use MeSH
- Cholinesterase Reactivators chemistry pharmacology MeSH
- Treatment Outcome MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Review MeSH
- Names of Substances
- Antidotes MeSH
- Chemical Warfare Agents MeSH
- Cholinesterase Inhibitors MeSH
- Oximes MeSH
- Cholinesterase Reactivators MeSH
Highly toxic organophosphorus inhibitors of acetylcholinesterase referred as nerve agents are considered to be among the most dangerous chemical warfare agents. The oximes represent very important part of medical countermeasures of nerve agent poisonings. They are used to reactivate the nerve agent-inhibited acetylcholinesterase. Despite long-term research activities, there is no single, broad-spectrum oxime suitable for the antidotal treatment of poisoning with all organophosphorus agents. There are two approaches how to increase and broaden the effectiveness of antidotal treatment of poisoning with nerve agents - to develop new structural analogues of currently available oximes and/or to combine currently available or newly developed oximes. The review describes the evaluation of the potency of newly developed oximes (especially the oxime K203) or combinations of oximes to reactivate nerve agent-inhibited acetylcholinesterase and to counteract the acute toxicity of nerve agents in comparison with single commonly used oxime (obidoxime, trimedoxime or HI-6).
References provided by Crossref.org
